首页> 外文OA文献 >DNA methylation patterns of candidate genes regulated by thymine DNA glycosylase in patients with TP53 germline mutations
【2h】

DNA methylation patterns of candidate genes regulated by thymine DNA glycosylase in patients with TP53 germline mutations

机译:胸腺嘧啶脱氧核糖核酸糖基化酶调控的TP53种系突变患者候选基因的DNA甲基化模式

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Li-Fraumeni syndrome (LFS) is a rare, autosomal dominant, hereditary cancer predisposition disorder. In Brazil, the p.R337H TP53 founder mutation causes the variant form of LFS, Li-Fraumeni-like syndrome. The occurrence of cancer and age of disease onset are known to vary, even in patients carrying the same mutation, and several mechanisms such as genetic and epigenetic alterations may be involved in this variability. However, the extent of involvement of such events has not been clarified. It is well established that p53 regulates several pathways, including the thymine DNA glycosylase (TDG) pathway, which regulates the DNA methylation of several genes. This study aimed to identify the DNA methylation pattern of genes potentially related to the TDG pathway (CDKN2A, FOXA1, HOXD8, OCT4, SOX2, and SOX17) in 30 patients with germline TP53 mutations, 10 patients with wild-type TP53, and 10 healthy individuals. We also evaluated TDG expression in patients with adrenocortical tumors (ADR) with and without the p.R337H TP53 mutation. Gene methylation patterns of peripheral blood DNA samples assessed by pyrosequencing revealed no significant differences between the three groups. However, increased TDG expression was observed by quantitative reverse transcription PCR in p.R337H carriers with ADR. Considering the rarity of this phenotype and the relevance of these findings, further studies using a larger sample set are necessary to confirm our results.
机译:Li-Fraumeni综合征(LFS)是一种罕见的常染色体显性遗传遗传易感性疾病。在巴西,p.R337H TP53奠基人突变导致LFS的变异形式,即Li-Fraumeni样综合征。已知即使在携带相同突变的患者中,癌症的发生和疾病发作的年龄也会发生变化,这种变异可能涉及多种机制,例如遗传和表观遗传学改变。但是,此类事件的参与程度尚未明确。众所周知,p53调节多种途径,包括胸腺嘧啶DNA糖基化酶(TDG)途径,该途径调节几种基因的DNA甲基化。这项研究旨在鉴定30例种系TP53突变,10例野生型TP53和10例健康的TDG途径潜在相关基因(CDKN2A,FOXA1,HOXD8,OCT4,SOX2和SOX17)的DNA甲基化模式个人。我们还评估了有和没有p.R337H TP53突变的肾上腺皮质肿瘤(ADR)患者的TDG表达。通过焦磷酸测序评估的外周血DNA样品的基因甲基化模式显示三组之间无显着差异。然而,通过定量逆转录PCR在带有ADR的p.R337H载体中观察到了TDG表达的增加。考虑到该表型的罕见性和这些发现的相关性,有必要使用更大的样本集进行进一步的研究以确认我们的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号